feed,title,long_url,short_url
Benzinga,UK's NICE Provisionally Rejects Coverage Of Pfizer-Merck KGaA's Bavencio As First-Line Therapy For Bladder Cancer,https://benzinga.com/general/biotech/21/05/21038115/uks-nice-provisionally-rejects-coverage-of-pfizer-merck-kgaas-bavencio-as-first-line-therapy-for-,https://j.mp/33yb12W
